Mammogen
Business Services · California, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
6b Liberty Ste 228, Aliso Viejo, Califor...Website
mammogen.bioRevenue
<$5 MillionIndustry
About Mammogen
Mammogen Org Chart
Is Mammogen your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Mammogen has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Mammogen launches new products
Website visits: Recent activity has been detected on your website
Check out if Mammogen is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Mammogen
Funding: Get notified immidiatlly once Mammogen has new funding data
Mammogen, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Mammogen recently announced quarterly report
Click to see if Mammogen had a recent Job posting/layoffs
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Mammogen
Compare insights from companies similar to Mammogen, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Mammogen is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Mammogen is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Mammogen.
Mammogen financials insights
Gather financial insights about Mammogen, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Series A
$30M
Mammogen Tech Stack
A closer look at the technologies used by Mammogen
Mammogen News & Media
Mammogen Taps Life Sciences Leadership Architect, Denise "DeeDee" DeMan, as Chairwoman of the Board of Directors
Renowned global builder of boards and executive teams aligns with leading women's health innovator, signaling next phase of commercial growth NEWPORT BEACH, Calif., June 30, 2025 /PRNewswire/ -- Mammogen, a women-built and women-led predictive health company redefining what's possible in...Mammogen to Showcase New Data at SABCS 2023 Demonstrating Clinical Efficacy of Its genTRU-breast™ qPCR Blood Test in Early-Stage Breast Cancer
Groundbreaking data unveiled in San Antonio: CLIA validated genTRU-breast assay achieves >99% sensitivity in stage I breast cancer NEWPORT BEACH, Calif., Dec. 1, 2023 /PRNewswire/ -- Mammogen, a pioneering leader in women's health and a subsidiary of early detection parent company, IVBH,...Mammogen Achieves CLIA Validation of gen-TRU-breast™ Assay
World's First Early Detection Blood Test to Unlock Stage I Diagnosis of Breast Cancer NEWPORT BEACH, Calif., Nov. 15, 2023 /PRNewswire/ -- Mammogen, a leader in women's health and bellwether subsidiary of early detection parent company IVBH, has announced the successful completion of...Mammogen Launches Dx Industry's First E-Commerce Marketplace, Strengthening its Leadership Position in Women's Health
Mammogen — a Female-led Precision Diagnostics Company — has Launched an Industry-first Online Marketplace Designed to Create a Tangible Bridge Between Science and Community NEWPORT BEACH, Calif., Sept. 13, 2022 /PRNewswire/ -- Mammogen, a leading women's health company specializing in...
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Mammogen
Mammogen is a womens health biotechnology company focused on developing non-invasive, RNA-based liquid biopsy tests for early cancer detection, particularly breast cancer. The company uses transcriptomics and blood-based biomarkers to identify disease signals at an early stage. It is currently in the clinical development phase, working toward valid... Read More

